GZGuoqiang Zhou

Guoqiang Zhou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Guoqiang Zhou has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Chenglong Shen

    Department of Gastrointestinal Surgery, Affiliated Changshu Hospital of Nantong University, Changshu, China

    6 shared publications
  • Jiazhe Shao

    Department of Gastrointestinal Surgery, Affiliated Changshu Hospital of Nantong University, Changshu, China

    6 shared publications
  • Haichen Liu

    Department of Gastrointestinal Surgery, Affiliated Changshu Hospital of Nantong University, Changshu, China

    5 shared publications
  • Fang Zhou

    Department of Gastrointestinal Surgery, Affiliated Changshu Hospital of Nantong University, Changshu, China

    4 shared publications
  • Zhiliang Shi

    Department of Gastrointestinal Surgery, Affiliated Changshu Hospital of Nantong University, The Second People’s Hospital of Changshu, Changshu, Suzhou, China

    3 shared publications
  • Bei Wang

    CAS Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China

    2 shared publications

Latest Publications

  • Open Access

    PITRM1-AS1 attenuates the ferroptosis of gastric cancer via TAF1-mediated KDM3B transcription

    by Chenglong Shen, Haichen Liu, Fang Zhou, Zhijie Wang, Yuchao Wang, Jiazhe Shao, Jian Guo, Zhiliang Shi, Guoqiang Zhou

  • Open Access

    LncRNA FOXP4-AS1 facilitates colorectal cancer invasion and migration by enhancing USP7 interaction with ZEB1

    by Xiaoling Yang, Chenglong Shen, Yuchen Yuan, Jiazhe Shao, Haichen Liu, Yichen Li, Guoqiang Zhou, Zhiliang Shi

    Colorectal cancer (CRC) poses a threat to the health of people worldwide. Long noncoding RNAs (lncRNAs) have been reported to play a key role in regulating carcinogenesis, including CRC. In this study, the levels of lncRNA FOXP4-AS1 were analyzed in CRC specimens and cells via qRT-PCR. The impacts of FOXP4-AS1 on CRC cell metastasis were investigated. Then, the silver staining assay, western blot, RIP, Co-IP, and immunofluorescence were conducted to explore and validate the molecular mechanisms by which FOXP4-AS1 affects CRC progression. We discovered that FOXP4-AS1 expression was markedly elevated in CRC. Functionally, FOXP4-AS1 knockdown suppressed CRC cell migration, invasion, and EMT. Also, FOXP4-AS1 silencing weakened CRC tumor growth in vivo. Mechanistically, we identified that FOXP4-AS1 functioned as a scaffold to simultaneously bind USP7 and ZEB1, and regulated the ubiquitination and expression of ZEB1 by binding to USP7. Rescue experiments demonstrated that USP7 inhibitor P005091 abolished the promotion of cell metastasis by FOXP4-AS1 overexpression. Furthermore, ZEB1 overexpression reversed the impact of silencing FOXP4-AS1 on cell metastasis. Collectively, our work revealed the molecular mechanism and role of FOXP4-AS1-mediated USP7-ZEB1 axis in CRC.


  • Open Access

    Overexpression of miR-195-5p Suppresses Gastric Cancer Progression by Regulating LAMP2-Mediated Autophagy

    by Chenglong Shen, Fang Zhou, Xiaolei Zhang, Jiazhe Shao, Yuchao Wang, Haichen Liu, Yichen Li, Guoqiang Zhou, Zhiliang Shi

    MiR-195-5p has been confirmed to be intimately linked to many cancers development, whereas its role in gastric cancer (GC) remains unelucidated. The objective of this study was to explore the potential function and mechanism of miR-195-5p in GC. First, miR-195-5p level in GC was analyzed based on clinical specimens and TCGA database. Then, the function of miR-195-5p in GC cells was detected via CCK-8, clone formation assay, flow cytometry, transwell, and wound healing assay. Subsequently, we explored the possible mechanism of miR-195-5p using KEGG analysis, database analysis, Western blot, and rescue assays. In this research, miR-195-5p was declined in GC and associated to malignant progression of GC. The introduction of miR-195-5p weakened cell growth, metastasis, and facilitated cell apoptosis. KEGG enrichment analysis indicated that miR-195-5p influenced the malignant progression of GC through mechanisms related to autophagy. MiR-195-5p overexpression leads to a diminution in cellular autophagy. Further studies identified that miR-195-5p bound to Lysosome-associated membrane protein 2 (LAMP2). Mechanism studies confirmed that miR-195-5p introduction attenuated cell growth, and this process was rescued by LAMP2 overexpression. Collectively, our work disclosed that miR-195-5p affected the malignant progression of GC by regulating LAMP2-mediated autophagy.

  • Open Access

    Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells

    by Wanlin Yang, Min Jin, Yuting Gu, Xiaonan Zhao, Lingqiao Zhu, Shan He, Hui Wang, Xinyuan Ding, Bei Wang, Tingwang Jiang, et al.

    Mesenchymal stromal cell (MSC)-based cell therapy is a promising approach for various inflammatory disorders based on their immunosuppressive capacity. Osteopontin (OPN) regulates several cellular functions including tissue repair, bone metabolism and immune reaction. However, the biological function of OPN in regulating the immunosuppressive capacity of MSCs remains elusive. This study aims to highlight the underlying mechanism of the proinflammatory cytokines affect the therapeutic ability of MSCs through OPN. MSCs in response to the proinflammatory cytokines were collected to determine the expression profile of OPN. In vitro T-cell proliferation assays and gene editing were performed to check the role and mechanisms of OPN in regulating the immunosuppressive capacity of MSCs. Inflammatory disease mouse models were established to evaluate the effect of OPN on improving MSC-based immunotherapy. We observed that OPN, including its two isoforms iOPN and sOPN, was downregulated in MSCs upon proinflammatory cytokine stimulation. Interestingly, iOPN, but not sOPN, greatly enhanced the immunosuppressive activity of MSCs on T-cell proliferation and thus alleviated the inflammatory pathologies of hepatitis and colitis. Mechanistically, iOPN interacted with STAT1 and mediated its deubiquitination, thereby inducing the master immunosuppressive mediator inducible nitric oxide synthase (iNOS) in MSCs. In addition, iOPN expression was directly downregulated by activated STAT1, which formed a negative feedback loop to restrain MSC immunosuppressive capacity. Our findings demonstrated that iOPN expression modulation in MSCs is a novel strategy to improve MSC-based immunotherapy.


  • Open Access

    Deficiency of UCHL1 results in insufficient decidualization accompanied by impaired dNK modulation and eventually miscarriage

    by Jie Zhang, Mingxing Xue, Jiefang Huang, Shan He, Lingqiao Zhu, Xiaonan Zhao, Bei Wang, Tingwang Jiang, Yanyun Zhang, Changhong Miao, et al.

    Background: Miscarriage is a frustrating complication of pregnancy that is common among women of reproductive age. Insufficient decidualization which not only impairs embryo implantation but disturbs fetomaternal immune-tolerance, has been widely regarded as a major cause of miscarriage; however, the underlying mechanisms resulting in decidual impairment are largely unknown. Methods: With informed consent, decidual tissue from patients with spontaneous abortion or normal pregnant women was collected to detect the expression profile of UCHL1. Human endometrial stromal cells (HESCs) were used to explore the roles of UCHL1 in decidualization and dNK modulation, as well as the mechanisms involved. C57/BL6 female mice (7–10 weeks old) were used to construct pregnancy model or artificially induced decidualization model to evaluate the effect of UCHL1 on mice decidualization and pregnancy outcome. Results: The Ubiquitin C-terminal hydrolase L1 (UCHL1), as a deubiquitinating enzyme, was significantly downregulated in decidua from patients with miscarriage, along with impaired decidualization and decreased dNKs. Blockage of UCHL1 led to insufficient decidualization and resultant decreased expression of cytokines CXCL12, IL-15, TGF-β which were critical for generation of decidual NK cells (dNKs), whereas UCHL1 overexpression enhanced decidualization accompanied by increase in dNKs. Mechanistically, the promotion of UCHL1 on decidualization was dependent on its deubiquitinating activity, and intervention of UCHL1 inhibited the activation of JAK2/STAT3 signaling pathway, resulting in aberrant decidualization and decreased production of cytokines associated with dNKs modulation. Furthermore, we found that inhibition of UCHL1 also disrupted the decidualization in mice and eventually caused adverse pregnancy outcome. Conclusions: UCHL1 plays significant roles in decidualization and dNKs modulation during pregnancy in both humans and mice. Its deficiency indicates a poor pregnancy outcome due to defective decidualization, making UCHL1 a potential target for the diagnosis and treatment of miscarriage. Graphical


  • Open Access

    LAMP2A regulates cisplatin resistance in colorectal cancer through mediating autophagy

    by Zhiliang Shi, Shuting Yang, Chenglong Shen, Jiazhe Shao, Fang Zhou, Haichen Liu, Guoqiang Zhou

    Background: Drug resistance is an important constraint on clinical outcomes in advanced cancers. LAMP2A is a limiting protein in molecular chaperone-mediated autophagy. This study was aimed to explore LAMP2A function in cisplatin (cis-diamminedichloroplatinum, DDP) resistance colorectal cancer (CRC) to seek new ideas for CRC clinical treatment. Methods: In this study, LAMP2A expression was analyzed by molecular experimental techniques,such as qRT-PCR and western blot. Then, LAMP2A in cells was interfered by cell transfection experiments. Subsequently, the function of LAMP2A on proliferation, migration, invasion, DDP sensitivity, and autophagy of CRC/DDP cells were further investigated by a series of experiments, such as CCK-8, transwell, and western blot. Results: We revealed that LAMP2A was clearly augmented in DDP-resistant CRC and was related to poor patient prognosis. Functionally, LAMP2A insertion remarkably CRC/DDP proliferation, migration, invasion ability and DDP resistance by strengthen autophagy. In contrast, LAMP2A knockdown limited the proliferation, migration, and invasion while heightened cellular sensitivity to DDP by restraining autophagy in CRC/DDP cells. Furthermore, LAMP2A silencing was able to curb tumor formation and enhance sensitivity to DDP in vivo. Conclusion: In summary, LAMP2A boosted malignant progression and DDP resistance in CRC/DDP cells through mediating autophagy. Clarifying LAMP2A function in DDP resistance is promising to seek cancer therapies biomarkers targeting LAMP2A activity.


  • Open Access

    LAMP2A regulates cisplatin resistance in colorectal cancer through mediating autophagy

    by Zhi-Liang Shi, Shuting Yang, Chenglong Shen, Jiazhe Shao, Fang Zhou, Haichen Liu, Guo-Qiang Zhou

    Background Drug resistance is an important constraint on clinical outcomes in advanced cancers. LAMP2A is a limiting protein in molecular chaperone-mediated autophagy. This study was aimed to explore LAMP2A function in cisplatin resistance colorectal cancer (CRC) to seek new ideas for CRC clinical treatment. Methods In this study, LAMP2A expression was analyzed by molecular experimental techniques, such as qRT-PCR and western blot. Then, LAMP2A in cells was interfered by cell transfection experiments. Subsequently, the function of LAMP2A on proliferation, migration, invasion, DDP sensitivity, and autophagy of CRC/DDP cells were further investigated by a series of experiments, such as CCK-8, transwell, and western blot. Results We revealed that LAMP2A was clearly augmented in DDP-resistant CRC and was releated to poor patient prognosis. Functionally, LAMP2A insertion remarkably CRC/DDP proliferation, migration, invasion ability and DDP resistance by strengthen autophagy. In contrast, LAMP2A knockdown limited the proliferation, migration, and invasion while heightened cellular sensitivity to DDP by restraining autophagy in CRC/DDP cells. Furthermore, LAMP2A silencing was able to curb tumor formation and enhance sensitivity to DDP in vivo. Conclusion In summary, LAMP2A boosted malignant progression and DDP resistance in CRC/DDP cells through mediating autophagy. Clarifying LAMP2A function in DDP resistance is promising to seek cancer therapies biomarkers targeting LAMP2A activity.

  • A tri-component semiconducting polymer with ultrahigh photothermal conversion efficiency as a biodegradable photosensitizer for phototheranostics

    by Yulan Gu, Guoqiang Zhou, Yujie Zhong, Litao Tan, Zuhui Zheng, Zihan Qiu, Bo Wei, Lei Shen, Jie Yang, Dengfeng Zou

    Semiconducting polymers usually with high photostability, reactive oxygen species (ROS) generation ability and photothermal conversion efficiency hold tremendous promise for phototherapy. In this study, a biodegradable tri-component semiconducting polymer (NDT) has been designed and synthesized for phototheranostics. NDT nanoparticles (NPs) obtained by nano-precipitation with an ultrahigh photothermal conversion efficiency (65.6%) could be degraded in the presence of hydrogen peroxide in the tumor microenvironment (TME). Such NPs show high phototoxicity towards human cervical cancer cells (HeLa) with laser irradiation as well as negligible dark toxicity. Furthermore, the in vivo study demonstrates that tumor growth was inhibited efficiently when mice were injected with NDT NPs, even with low power laser irradiation (0.2 W cm−2). In contrast, higher power density (0.5 W cm−2) led to complete tumor suppression. No side effects were observed towards normal tissues, which was confirmed by the H&E stained pictures of the normal tissues, including heart, liver, spleen, lung and kidney. Further, hematological, liver and renal function parameters indicate the biosafety of NDT NPs.


  • Open Access

    Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p

    by Zhiliang Shi, Chenglong Shen, Cheng Yu, Xiaoling Yang, Jiazhe Shao, Jian Guo, Xinguo Zhu, Guoqiang Zhou

    We aimed to study the role of LINC00997 in the metastasis of colorectal cancer (CRC). LINC00997 and miR-512-3p expression in the primary colorectal cancer (NCRC) tissues and metastatic colorectal cancer (MCRC) tissues were detected using RT-qPCR. The Cancer Genome Atlas database was used to evaluate LINC00997 levels in the NCRC and MCRC tissues, and the correlations of LINC00997 expression with distant metastasis (M), regional lymph node metastasis (N), age and tumor stage were analyzed. Subsequently, RT-qPCR was performed to determine the expression of metastasis-related genes in MCRC tissues and analyze the correlation of LINC00997 or miR-512-3p level with the protein expression of metastasis-related genes. In vitro, LINC00997 expression in several CRC cell lines was examined. After LINC00997 silencing, cell invasion and migration were evaluated with Transwell and wound healing assays, respectively. The expression of metastasis- and EMT-related proteins was measured. Additionally, the potential interaction between LINC00997 and miR-512-3p was verified using a luciferase reporter assay. Rescue assays were conducted to clarify the regulatory effects of LINC00997 and miR-512-3p on CRC development. Results revealed that LINC00997 was frequently overexpressed in MCRC tissues, which was positively related to the tumor metastasis and stage. Additionally, LINC00997 was significantly elevated in CRC cells and LINC00997 silencing inhibited the invasion, migration and EMT of CRC cells, which was restored by miR-512-3p inhibitor. Luciferase reporter assay confirmed that LINC00997 could target miR-512-3p. In conclusion, LINC00997 regulated the metastasis of CRC by targeting miR-512-3p, providing some insights into the regulatory mechanism of CRC. Graphical Abstract